Peter Valent

Focus on clinical research:

• Diagnostics, prognosis and therapy optimization in AML
• Diagnostics, prognosis and therapy optimization in CML
• Prognostic factors and therapy optimization in MDS
• Diagnostics, prognosis and therapy optimization in mastocytosis
• Therapy optimization in clinical haematology at an advanced age
• Establishment of personalized medicine for myeloid neoplasms

Focus on basic research:

• Basophilic granulocytes and tissue mast cells
• Pathophysiology of AML, CML, MDS and mastocytoses
• Eosinophilic granulocytes and eosinophilic leukemias
• Oncogene-dependent signal transduction in leukemia cells
• Identification of new therapeutic targets in neoplastic cells
• Characterization and eradication of leukemic stem cells
• Synergistic effect of new antileukemic drugs

Coordination of networks:

• European Competence Network for Mastocytosis (ECNM)
• International Cooperative Working Group on Eosinophilic Diseases (ICOG-EO)
• Special Research Area (SFB) Myeloproliferative Neoplasia (SFB-F47)
• Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO)
• Clinical Center of Excellence of the MDS Foundation
• Center of Excellence and Reference Center of the ECNM

Honors/awards:

1989: Paracelsus Prize of the Austrian Society for Internal Medicine
1989: Karl Landsteiner Prize of the Austr. Soc. f. Allergol. and Immunology
1990: Prize of the Hoechst company
1991: Wilhelm-Türk-Prize of the Austr. Soc. f. Hematology and Oncology
1991: Theodor Billroth Prize of the Vienna Medical Association
1992: Prize of the Hoechst company
1992: Denk Prize of the Austr. Soc. f. Hematology and Oncology
1992: Austrian Sandoz Prize
1994: Denk Prize of the Austr. Soc. f. Hematology and Oncology
1995: Theodor Billroth Prize of the Vienna Medical Association
1995: Mack-Forster Prize of the European Soc. for Clinical Investigation
2006: Central European Prize for Interdisciplinary Cancer Research

Pubmed Publication list